Publication: Comparison of composite indices with global synovitis score on ultrasound for detecting remission
dc.contributor.coauthor | Ölmez, Merve Özata | |
dc.contributor.coauthor | Günal, Esen Kasapoğlu | |
dc.contributor.coauthor | Üreyen, Sibel Bakırcı | |
dc.contributor.coauthor | Keskin, Havva | |
dc.contributor.coauthor | Çobanoğlu, Erim | |
dc.contributor.coauthor | Aydın, Sibel Zehra | |
dc.contributor.department | N/A | |
dc.contributor.kuauthor | Öztürk, Ayşe Bilge | |
dc.contributor.kuauthor | Yeter, Havva Gökçe | |
dc.contributor.kuprofile | Faculty Member | |
dc.contributor.kuprofile | Undergraduate Student | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.yokid | 147629 | |
dc.contributor.yokid | N/A | |
dc.date.accessioned | 2024-11-09T23:26:15Z | |
dc.date.issued | 2018 | |
dc.description.abstract | We aimed to compare composite indices with Ultrasound Global Synovitis Score (GLOESS) for remission in rheumatoid arthritis (RA). RA patients in remission according to the clinician were investigated with Disease Activity Score28 (DAS28), Clinical Disease Activity Index (CDAI), Simplified Disease Activity Index (SDAI), and RAPID-3 (Routine Assessment of Patient Index Data 3). Ultrasonography was performed using the GLOESS scores. Patients in CDAI-remission had lower GLOESS (median (IQR), 5(3-9.75) vs 7(4-11.75), p = 0.048) with a similar trend in SDAI (5(3-9.25) vs 7(4-11.25), p = 0.064). This was not observed with DAS28-CRP and RAPID3. Our results show that CDAI is superior to other indices to assess remission in RA. | |
dc.description.indexedby | WoS | |
dc.description.indexedby | Scopus | |
dc.description.indexedby | PubMed | |
dc.description.issue | 4 | |
dc.description.openaccess | NO | |
dc.description.publisherscope | International | |
dc.description.sponsorship | Abbvie | |
dc.description.sponsorship | Novartis | |
dc.description.sponsorship | UCB | |
dc.description.sponsorship | Sanofi | |
dc.description.sponsorship | Pfizer SZA received grants and/or honoraria from Abbvie, Novartis, UCB, Sanofi and Pfizer. | |
dc.description.volume | 37 | |
dc.identifier.doi | 10.1007/s10067-017-3925-x | |
dc.identifier.eissn | 1434-9949 | |
dc.identifier.issn | 0770-3198 | |
dc.identifier.quartile | Q3 | |
dc.identifier.scopus | 2-s2.0-85035142909 | |
dc.identifier.uri | http://dx.doi.org/10.1007/s10067-017-3925-x | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/11522 | |
dc.identifier.wos | 428989500033 | |
dc.keywords | CDAI | |
dc.keywords | RAPID3 | |
dc.keywords | Remission | |
dc.keywords | Rheumatoid arthritis | |
dc.keywords | SDAI | |
dc.keywords | US-Gloess | |
dc.language | English | |
dc.publisher | Springer London Ltd | |
dc.source | Clinical Rheumatology | |
dc.subject | Rheumatology | |
dc.title | Comparison of composite indices with global synovitis score on ultrasound for detecting remission | |
dc.type | Journal Article | |
dspace.entity.type | Publication | |
local.contributor.authorid | 0000-0003-0166-424X | |
local.contributor.authorid | N/A | |
local.contributor.kuauthor | Öztürk, Ayşe Bilge | |
local.contributor.kuauthor | Yeter, Havva Gökçe |